You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 17, 2025

Details for Patent: 10,047,097


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 10,047,097
Title:Method of treatment using substituted pyrazolo[1,5-a] pyrimidine compounds
Abstract: Compounds useful in the synthesis of compounds for treating pain, cancer, inflammation, neurodegenerative disease or Typanosoma cruzi infection in a mammal.
Inventor(s): Haas; Julia (Boulder, CO), Andrews; Steven W. (Boulder, CO), Jiang; Yutong (Boulder, CO), Zhang; Gan (Boulder, CO)
Assignee: Array BioPharma Inc. (Boulder, CO)
Application Number:15/860,948
Patent Claim Types:
see list of patent claims
Use; Formulation; Dosage form;
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of a U.S. Patent: A Detailed Guide Using the Example of U.S. Patent 10,047,097

Introduction

When analyzing the scope and claims of a U.S. patent, it is crucial to understand the various components and tools available for patent research. This article will provide a comprehensive guide on how to conduct such an analysis, using U.S. Patent 10,047,097 as an example.

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention for which protection is sought. These claims must be clear, concise, and fully supported by the patent's description and drawings[3].

Types of Claims

  • Independent Claims: These claims stand alone and do not depend on other claims.
  • Dependent Claims: These claims refer back to and further limit another claim or claims.
  • Method Claims: Describe a process or method.
  • Apparatus Claims: Describe a device or system.
  • Composition of Matter Claims: Describe a chemical compound or mixture.

Tools for Patent Research

Several tools and databases are available for conducting thorough patent research.

Patent Public Search

The USPTO's Patent Public Search tool is a powerful resource that replaced older tools like PubEast, PubWest, PatFT, and AppFT. It offers two modern interfaces, enhancing access to prior art and improving the overall search process[1].

Global Dossier

This service provides access to the file histories of related applications from participating IP Offices, including the IP5 Offices. It helps users identify patent families, view dossier, classification, and citation data, and download documents[1].

Patent and Trademark Resource Centers (PTRCs)

These centers offer local search resources and training in patent search techniques, making them invaluable for researchers[1].

Common Citation Document (CCD)

The CCD consolidates prior art cited by all participating offices for the family members of a patent application, allowing users to visualize search results from multiple offices on a single page[1].

Analyzing U.S. Patent 10,047,097

Patent Details

To analyze U.S. Patent 10,047,097, start by retrieving the patent document from the USPTO's Patent Public Search or other patent databases.

Title and Abstract

  • Title: The title provides a brief description of the invention.
  • Abstract: The abstract gives a concise summary of the invention.

Background of the Invention

This section provides context and explains the problem the invention solves.

Summary of the Invention

This section outlines the key aspects of the invention.

Detailed Description of the Invention

Here, you will find detailed explanations of the invention, including drawings and figures.

Claims Analysis

Independent Claims

Identify the independent claims, which define the broadest scope of the invention.

Dependent Claims

Analyze the dependent claims, which further limit the independent claims and provide additional details.

Claim Construction

Understand the claim construction, which involves interpreting the meaning of the claim terms. This is crucial in patent litigation, as seen in cases like Contour IP Holding LLC v. GoPro, Inc.[2].

Prior Art and Citation Analysis

Use tools like the Common Citation Document (CCD) to identify prior art cited by various patent offices. This helps in understanding how the invention differs from existing technologies[1].

Patent Scope and Measurements

The USPTO's Patent Claims Research Dataset can provide insights into patent scope measurements. This dataset includes detailed information on claims from U.S. patents and applications, helping to analyze the breadth and depth of the patent claims[3].

Legal Considerations

Patentability

Ensure the claims are directed to patent-eligible subject matter. The Supreme Court's "Alice" test is often used to determine if claims are directed to abstract ideas, which are not patentable[2].

Infringement Analysis

Analyze whether other products or processes infringe on the patent claims. This involves comparing the claims with the allegedly infringing product or process.

Practical Applications

Licensing and Enforcement

Understanding the scope and claims of a patent is crucial for licensing and enforcement. It helps in identifying potential infringers and negotiating licensing agreements.

Innovation and R&D

For researchers and developers, analyzing patent claims can guide innovation by identifying areas not covered by existing patents.

Case Study: Contour IP Holding LLC v. GoPro, Inc.

In the case of Contour IP Holding LLC v. GoPro, Inc., the court had to determine whether GoPro's products infringed on Contour's patents. The analysis involved claim construction and determining whether the claims were directed to patent-eligible subject matter. This case highlights the importance of thorough claim analysis in patent litigation[2].

Key Takeaways

  • Thorough Claim Analysis: Understanding the claims is essential for determining the scope of protection.
  • Use of Patent Databases: Tools like Patent Public Search, Global Dossier, and CCD are vital for comprehensive patent research.
  • Legal Considerations: Ensure claims are directed to patent-eligible subject matter and analyze for potential infringement.
  • Practical Applications: Accurate analysis aids in licensing, enforcement, and guiding innovation.

FAQs

What is the purpose of the Common Citation Document (CCD)?

The CCD provides a single point of access to up-to-date citation data relating to the patent applications of the IP5 Offices, consolidating prior art cited by all participating offices[1].

How do I conduct a preliminary U.S. patent search?

Use the USPTO's Patent Public Search tool and follow the multi-step strategy outlined in the USPTO's web-based tutorial[1].

What is the difference between independent and dependent claims?

Independent claims stand alone and define the broadest scope of the invention, while dependent claims refer back to and further limit another claim or claims[3].

How do I determine if a patent claim is directed to patent-eligible subject matter?

Use the Supreme Court's "Alice" test to determine if the claims are directed to abstract ideas and whether they include elements that transform them into a patent-eligible application[2].

What resources are available for analyzing patent scope measurements?

The USPTO's Patent Claims Research Dataset provides detailed information on claims from U.S. patents and applications, including newly-developed measures of patent scope[3].

Sources

  1. USPTO - Search for Patents: https://www.uspto.gov/patents/search
  2. CAFC - Contour IP Holding LLC v. GoPro, Inc.: https://cafc.uscourts.gov/opinions-orders/22-1654.OPINION.9-9-2024_2381170.pdf
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Harvard Business School - Patent Search: A Comparative Table of Databases: https://asklib.library.hbs.edu/faq/266950
  5. ACUS - U.S. Patent Small Claims Court: https://www.acus.gov/research-projects/us-patent-small-claims-court

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,047,097

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861-001 Nov 26, 2018 RX Yes No 10,047,097 ⤷  Try for Free METHOD OF TREATING SOLID TUMORS THAT EXHIBIT AN NTRK GENE FUSION AFTER SURGICAL RESECTION ⤷  Try for Free
Bayer Hlthcare VITRAKVI larotrectinib sulfate CAPSULE;ORAL 210861-002 Nov 26, 2018 RX Yes Yes 10,047,097 ⤷  Try for Free METHOD OF TREATING SOLID TUMORS THAT EXHIBIT AN NTRK GENE FUSION AFTER SURGICAL RESECTION ⤷  Try for Free
Bayer Healthcare VITRAKVI larotrectinib sulfate SOLUTION;ORAL 211710-001 Nov 26, 2018 RX Yes Yes 10,047,097 ⤷  Try for Free METHOD OF TREATING SOLID TUMORS THAT EXHIBIT AN NTRK GENE FUSION AFTER SURGICAL RESECTION ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 10,047,097

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
European Patent Office 3106463 ⤷  Try for Free 301033 Netherlands ⤷  Try for Free
European Patent Office 3106463 ⤷  Try for Free PA2020504 Lithuania ⤷  Try for Free
European Patent Office 3106463 ⤷  Try for Free CA 2020 00013 Denmark ⤷  Try for Free
European Patent Office 3106463 ⤷  Try for Free 122020000012 Germany ⤷  Try for Free
European Patent Office 3106463 ⤷  Try for Free LUC00150 Luxembourg ⤷  Try for Free
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.